Company Name

Industry

Location

Revenue

Employees

Good Therapeutics

Biotechnology

United States, Washington

$1B and Over

11-50

Vanguard Laboratory

Biotechnology

United States, Washington

$1B and Over

11-50

Talus Bio

Biotechnology

United States, Washington

$500M to $1B

11-50

Bonum Therapeutics

Biotechnology

United States, Washington

$500M to $1B

11-50

Allen Institute for Immunology

Biotechnology

United States, Washington

$250M to $500M

11-50

InduPro

Biotechnology

United States, Washington

$250M to $500M

11-50

LSBio | LifeSpan BioSciences

Biotechnology

United States, Washington

$25M to $50M

11-50

Universal Cells

Biotechnology

United States, Washington

$25M to $50M

11-50

StratusG

Biotechnology

United States, Washington

$10M to $25M

11-50

BIO Ventures for Global Health

Biotechnology

United States, Washington

$10M to $25M

11-50

HDT Bio

Biotechnology

United States, Washington

$10M to $25M

11-50

ActX

Biotechnology

United States, Washington

$10M to $25M

11-50

Phase Genomics

Biotechnology

United States, Washington

$10M to $25M

11-50

A-Alpha Bio

Biotechnology

United States, Washington

$10M to $25M

11-50

PharmaIN

Biotechnology

United States, Washington

$10M to $25M

11-50

Blaze Bioscience

Biotechnology

United States, Washington

$10M to $25M

11-50

SystImmune

Biotechnology

United States, Washington

$10M to $25M

11-50

Icosavax

Biotechnology

United States, Washington

$10M to $25M

11-50

Laxco

Biotechnology

United States, Washington

$10M to $25M

11-50

Visus Therapeutics

Biotechnology

United States, Washington

$10M to $25M

11-50